Leslie Trigg Sells 10,227 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 10,227 shares of the company’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $1.29, for a total value of $13,192.83. Following the transaction, the chief executive officer now directly owns 894,624 shares in the company, valued at $1,154,064.96. The trade was a 1.13 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Leslie Trigg also recently made the following trade(s):

• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $4,516.00.

Outset Medical Stock Performance

Shares of NASDAQ:OM traded down $0.17 during midday trading on Tuesday, hitting $1.10. The company’s stock had a trading volume of 3,730,312 shares, compared to its average volume of 3,236,809. The stock has a market capitalization of $57.80 million, a price-to-earnings ratio of -0.40 and a beta of 2.05. The stock’s 50 day simple moving average is $0.98 and its 200 day simple moving average is $1.50. The company has a debt-to-equity ratio of 4.12, a quick ratio of 5.04 and a current ratio of 6.49. Outset Medical, Inc. has a fifty-two week low of $0.44 and a fifty-two week high of $5.67.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada restated a “sector perform” rating and issued a $3.00 price objective on shares of Outset Medical in a report on Tuesday.

Hedge Funds Weigh In On Outset Medical

A number of institutional investors and hedge funds have recently bought and sold shares of OM. Millennium Management LLC lifted its position in Outset Medical by 58.8% in the second quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after purchasing an additional 719,412 shares during the period. Massachusetts Financial Services Co. MA increased its stake in Outset Medical by 118.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock valued at $5,925,000 after acquiring an additional 834,663 shares during the period. GSA Capital Partners LLP lifted its stake in Outset Medical by 924.7% during the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock worth $753,000 after purchasing an additional 1,003,135 shares during the period. Acadian Asset Management LLC grew its stake in shares of Outset Medical by 5.2% in the 2nd quarter. Acadian Asset Management LLC now owns 819,563 shares of the company’s stock valued at $3,154,000 after purchasing an additional 40,321 shares during the period. Finally, Marshall Wace LLP raised its holdings in shares of Outset Medical by 487.8% in the 2nd quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock worth $1,210,000 after buying an additional 260,740 shares in the last quarter.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.